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INTRODUCTION:  Small  intestine  melanomas  are  rare  and  the  most  of  them  are  metastases  from  primary
cutaneous  neoplasms.
PRESENTATION  OF  CASE:  Below,  we report  two  cases  of small  intestine  metastatic  melanoma  with  very
different  clinical  presentation.eywords:
ntestinal
elanoma
DISCUSSION: Still  now,  primary  versus  metastatic  origin  is  often  unclear.  Small  bowel  melanoma  is often
asymptomatic.  However,  clinical  picture  can  be various;  it may  occurs  with  non  speciﬁc  symptoms  and
signs  of  gastro-intetstinal  involvement,  like  chronic  abdominal  pain,  occult  or gross  bleeding  and  weight
loss,  or  with  an  emergency  picture  due  to intestinal  intussusception,  obstruction  or,  rarely,  perforation.
CONCLUSION: Small  bowel  melanoma  is rare and  the  diagnosis  done  late.  Imaging  techniques  are  recom-
mended  in order  to obtain  early  diagnosis  of gastrointestinal  metastases.
gical © 2012 Sur
. Background
Primary and secondary malignant tumor of small intestine is
are. Most melanomas of the small intestine are metastases from
rimary cutaneous lesions, but melanoma can also develop as a
rimary mucosal neoplasm in the gastrointestinal tract [GI]. We
eport two cases of metastases of malignant melanoma of small
owel followed by a review of the literature.
. Case report 1
A  17-year-old man  was admitted to our Department in January
000 due two-days of diffuse abdominal pain, constipation and
omiting. His past medical history was characterized by a diagno-
is of cutaneous Clark V-level malignant melanoma in the occipital
egion made in January 1997, and treated with a surgical exci-
ion followed by immunotherapy. In September 1999, this tumor
elapsed with a metastases in the left lateral-cervical region with
earby lymph node involvement. A complete markers screening
howed an improvement of beta-HCG [8.5 mUI/ml; normal range
–4 mUI/ml] and S100 [583 ng/l; normal range <250 ng/l]. A total
ody CT scan showed also the presence of partially necrotic lymph
odes in the left pulmonary hilum and in the abdominal cavity
ssociated with a thickening of the some loops of small intestine
ith many bigger mesenteric lymph nodes. For this reason he had
hemotherapy. At the admission in our Unit, patient presented
ever, tachycardia, and a distended tender abdomen. Laboratory
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data revealed a moderate anemia and a slight leukocytosis. A
laparotomy was performed. The exploration of the abdominal cav-
ity showed a free enteric ﬂuid and a mass of about 5 cm in diameter
that included a neoplasm and a perforated ileal loop sided at 50 cm
from ileocecal valve. An another neoplasm of 2 cm of diameter was
found 70 cm from ligament of Treitz. The resection of both jeju-
nal loops including the lesions and the related meso was done
performing a manual entero-entero anastomosis. The pathologic
examination of surgical specimen conﬁrmed the size of both neo-
plasm detected at the laparotomy and showed that both tumors,
at the section, had a white-yellowish aspect. The biggest neoplasm
presented a large ulceration in the mucosa with an area of perfora-
tion. The histological analysis showed the presence of epithelioid
cells from melanoma with malignant invasion of ten lymph nodes.
At the immunohistochemical examination a strongly reactive for
HMB-45, MelanA and S100 were detected. A diagnosis of melanoma
metastases of the small intestine was  done (Fig. 1a and b). The
patient showed uncomplicated postoperative course and do not
need of any adjuvant treatment. Two months after operation, both
gastyroscopy and colonoscopy were performed resulting negative
for neoplastic lesions. He died 10 months after intestinal resection.
3. Case report 2
A  60-year-old woman was  admitted to our department in
February 2008 due to anemia and diffuse abdominal pain of dura-
tion of about one week. Her past medical history was  unremarkable.
At physical examination, an ovalar tumor of about 10 × 5 cm in size
Open access under CC BY-NC-ND license.was detected in the mesogastric region, leading us to considered
the possibility of a gastric or duodenal neoplasm. Laboratory data
were within normal limits except for a moderate anemia. Gastroen-
terological workup, including gastroscopy and colonoscopy, was
 BY-NC-ND license.
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tig. 1. (a) A global view of lymph nodes analyzed in hematossilin-eosin that shows
b)  a particular of melanocytes population associated with hemosiderin deposit. O
00×); (c) immunohistochemical assay for Melan-A shows positive cells among ne
ormal. A computerized tomography [CT] scan revealed a regular
ircumferential thickness of jejune loop with a moderate swelling
pstream in mesogastric region, suggesting the presence of a neo-
lasm and a series of nodular lesions in the right side of parietal
eritoneum of about 5 cm in size. A complete neoplastic markers
creening resulted only in a slight rise of HCG [6.64 mUI/ml; nor-
al range 0–4 mUI/ml]. She underwent to a laparotomy, due to
he presence of jejunal neoplasm, which revealed the presence of
wo jejunal masses; the greatest one was localized 60 cm from lig-
ment of Treitz, the second mass was found 70 cm from the ﬁrst.
oreover, a neoplasm of about 5 cm of diameter was found in
he right side of parietal peritoneum. A double jejunum resection
Fig. 2) with end-to-end anastomosis associated with excision of
eritoneal neoplasm was performed.
The pathology report conﬁrmed the presence of a white-
ellowish tumour of 7 × 4 × 2 cm in size in the proximal jejunum,
he neoplasm extended up to the mucosa causing focal areas of
lceration. A 3 × 2 × 1.3 cm tumour was found in the distal jejunum
ith similar macroscopic characteristics. The histological exam-
nation showed that tissue was highly atypical, with an epithelial
spect (Fig. 3a). Immunohistochemical stains revealed that the neo-
lastic cells were strongly reactive for HMB-45, Melan A, S100
Fig. 3b). A mesenteric lymph node was affected by metastasis.
his picture was compatible for metastases from melanoma. The
ost-operative course was regular and uneventful. The patient
nderwent a deep clinical and laboratory examinations in order
o ﬁnd a possible cutaneous lesion, and an Ophthalmologic consul-
ation, but no primary malignant melanoma was found. Therefore,
eoplasms were considered metastases of a spontaneous regres-
ion of a cutaneous melanoma. After surgery the patient underwent
o six chemotherapy sessions. In October 2009 the patient noticed
he arising of a neoplasm in the left dorsal-lumbar region, which
Fig. 2. Surgical specimen after double jejunum resection.etastatic area subside in the sub capsular region (E–E; original magniﬁcation 25×);
right it is presents a residual lymph node parenchima (E–E; original magniﬁcation
 lymphoid cells. (Melan-A, original magniﬁcation 100×.)
the CT showed to be 8.5 × 4.4 × 3 cm in size, solid, and heteroge-
neously vascularised with necrotic areas. The tumour was excised.
The histological and immunohistochemical examination revealed
that the cells were strongly reactive for HMB-45, Melan A, MIB-1:
therefore it was  made diagnosis of metastases of melanoma. Three
months later she developed recurrent multiple bone metastases
and in March 2010 she died.
4.  Discussion
GI tract malignant melanoma is an uncommon form of neoplasm
that may  be either primary or metastatic; it can be localized in
different sites from the oral cavity up to anus and the most com-
mon includes small bowel.1 The distinction between primary or
metastatic small bowel melanoma remain difﬁcult to establish. Pri-
mary intestinal melanoma seems to be associated with a worse
prognosis and a more aggressive behaviour due to rapidly growth
for a rich vascular and lymphatic supply of the intestinal mucosa
respect to metastatic one.2 Mishima.3 postulated that the primary
melanoma of the small intestine might arise from schwannian neu-
roblast cells associated with the autonomic innervations of the
gut. Other authors reported its origin in melanoblastic cells of the
neural crest which migrate to the distal ileum through omphalo-
mesenteric canal4or in APUD cells. However, some researchers
suggest that primary melanoma of the small bowel does not
exist as a separate clinical entity and that all small bowel
melanomas are metastatic lesions from unknown or regressed
primary cutaneous melanoma.5 The frequency of an unknown
primary cutaneous tumor site is estimated to be about 26% of
cases.6
Blecker et al.1 propose the following criteria for a diagnosis of
primary melanoma of small bowel: presence of a solitary mucosal
lesion in the intestinal epithelium, absence of melanoma or atyp-
ical melanocytic lesions of the skin and presence of intramucosal
melanocytic lesions in the overlying or adjacent intestinal epithe-
lium.
GI melanoma metastases are present in more than a quarter of
patients with melanoma at autopsy, but only in 1–4% of patients
the diagnosis is made during the life.7 Metastases of melanoma are
often multiple in the GI tract and can also be extra-intestinal.
Bender et al.,8 deﬁned four different types of metastatic
melanoma  of the small bowel: cavitary, inﬁltrating, exoenteric,
and polypoid [often called a target or bull’s-eye lesion]. These four
types are not always distinct. In addition, they may  be either pig-
mented or amelanotic. Histological features of metastatic intestinal
melanoma that develop after spontaneous regression of primary
cutaneous melanoma include lymphocytic inﬁltration of the dermis
with melanophages, vascular proliferation and reparative ﬁbrosis.9
A clear distinction between primary intestinal melanoma and
intestinal metastatic deposits can be difﬁcult when considering
histopathological features alone.10
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wig. 3. (a) Submucosal neoplastic nodule of intestinal metastatic melanoma. Overly
o  Melan A (Melan A; original magniﬁcation 400×).
Recent studies show how the high incidence of metastases of
elanoma in the small bowel may  be due to the presence, on
uman melanoma cells, of a particular chemokine, CCR9, that it
s likely a “homing receptor” for melanoma of the small bowel. In
act, it participates in the enhanced motility of melanoma cells and
ts ligand, CCL25, is strongly expressed in the small bowel.11
The time frame period between diagnosis of primary malignant
elanoma and the identiﬁcation of metastases at a gastrointestinal
evel varies between 2 and 180 months and most of them is detected
nly during autopsy.6
The melanoma of the small bowel is often asymptomatic. When
t produce symptoms, they can be varying from chronic abdomi-
al pain [17–64%], occult or gross bleeding [26–84%] and weight
oss [10–47%].6 Due to the unspeciﬁed clinical picture it needs to
xclude other causes of abdominal pain in order to be sure of the
iagnosis. Sometimes, small bowel melanoma occurs with an emer-
ency clinical picture due to intestinal obstruction or intestinal
ntussusceptions and, rarely, to bowel perforation. To date, only
ix cases of perforation due to melanoma intestinal metastasis
ave been reported11–15 and less than twenty cases of small bowel
ntussusception secondary to metastatic skin melanoma have been
eported up to 2007.16
Due the rarity of occurrence of small bowel melanoma, the
nspeciﬁcity of clinical complaints and the difﬁculty to explore the
ntestinal loops with the common instrumental procedures, preop-
rative diagnosis of small intestine melanoma results often difﬁcult
o perform. Different imaging techniques [Echo, TC, PET, capsule
ndoscopy] may  give a suspicion of intestinal neoplasm, however
he ﬁnal diagnosis can be obtained only after surgical exploration.
he sporadic nature and the small numbers of patients reported
n the literature with a primary small bowel melanoma led the
urgeons to not gain a standardization of treatment. A wide intesti-
al resection including the resection of the mesentery with lymph
odes remains the treatment of choice also because it seems to be
ssociated with low morbidity and the mortality rate; in case of
bstruction, perforation or serious hemorrhage an emergency sur-
ical treatment is mandatory. Before considering a possible elective
urgery, In case of non-urgent symptoms, ﬁrst it is important to
alue intestinal or extra-intestinal spread. Gutman et al.,17 stud-
ed indications for surgery of GI melanoma metastases. Half of
heir patients underwent elective surgery and 22% required emer-
ency surgery for bowel obstruction or gross GI hemorrhage. They
eported that the indications for surgery both elective and emer-
ency had no impact on postoperative survival. On the other hand,
llila et al. reported that surgical intervention improved survival
igniﬁcantly, especially when resection was complete on micro-
copic examination.18 In their study, the median survival period
fter complete surgical resection of GI metastases was 48.9 months
hile only 5.4 months after incomplete resection and the 5-yearscosa is normal (E–E; Original magniﬁcation 100×); (b) neoplastic cells are positive
survival  rate was 41% after complete resection. Branum et al. also
reported signiﬁcantly longer survival after complete resection of
GI metastases than after incomplete resection, the mean survival
period being 31.6 months versus 9.6 months.19 Actually a standard-
ized systemic therapy is missing. Treatment of metastatic disease
include chemotherapy, immunotherapy and target-therapy. They
can be useful as a palliative treatment in metastatic intestinal
melanoma but at the moment their role is unclear.20
5. Conclusion
Primary melanoma of small bowel is rare; they are always
metastatic lesions from regressed primary cutaneous melanoma.
The diagnosis is often late and the patients undergo emergency
surgery.
Because the high incidence of gastrointestinal metastases, in
patients with an history of cutaneous melanoma who  complaints
abdominal pain and/or anemia, the employ of the modern imaging
techniques applied for the study of small bowel is recommended
in order to obtain an early diagnosis of gastrointestinal metastases.
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